## Diagnosis of IgE-Mediated Hypersensitivity (Type I) to Penicillin ### Clinical Context This patient presents with classic anaphylaxis — a Type I (IgE-mediated) hypersensitivity reaction with rapid onset urticaria, angioedema, bronchospasm, and hypotension following penicillin exposure. After acute management, the question asks for the **most specific** investigation to confirm IgE-mediated hypersensitivity. ### Investigation of Choice: Intradermal Skin Test with Penicillin G **Key Point:** Intradermal skin testing with penicillin (using both the major determinant — benzylpenicilloyl-polylysine — and minor determinants including penicillin G) is the **gold standard and most specific in-vivo test** for confirming IgE-mediated penicillin hypersensitivity, with specificity of 90–95% and sensitivity of 70–90%. **High-Yield:** Skin testing directly detects mast cell-bound IgE antibodies by eliciting a wheal-and-flare reaction upon intradermal injection of penicillin determinants. This is the most specific method because it tests the actual effector mechanism (mast cell degranulation via cross-linking of surface-bound IgE) rather than measuring circulating free IgE. ### Why Intradermal Skin Test is Most Specific | Feature | Intradermal Skin Test | Serum Penicillin-Specific IgE | | --- | --- | --- | | **Specificity** | 90–95% (**highest**) | >90% | | **Sensitivity** | 70–90% | 50–80% (lower) | | **Mechanism tested** | Mast cell-bound IgE (in-vivo) | Circulating free IgE (in-vitro) | | **Gold standard status** | Yes — per EAACI/AAAAI guidelines | Adjunct/alternative | | **Timing** | Must defer 2–4 weeks post-acute reaction | Can be done sooner | | **Risk** | Small anaphylaxis risk (performed by trained personnel) | No risk | **Clinical Pearl (per Roitt's Immunology and EAACI Drug Allergy Guidelines):** Skin testing with penicillin determinants is the **reference standard** for diagnosing IgE-mediated penicillin allergy. Serum-specific IgE has lower sensitivity (50–80%) and may miss true allergy. The question asks for the **most specific** test — intradermal skin testing fulfills this criterion and is the accepted gold standard when performed 2–4 weeks after the acute event. ### Why Other Options Are Incorrect - **Serum penicillin-specific IgE (A):** Useful and safe during acute phase, but sensitivity is lower (50–80%) and it is not the gold standard — it is an adjunct when skin testing is contraindicated. - **Complement levels C3, C4 (C):** Relevant for Type II/III hypersensitivity (immune complex/complement-mediated); not useful for Type I IgE-mediated reactions. - **Histamine levels in serum (D):** Histamine is an acute-phase mediator that degrades rapidly (half-life ~15–20 minutes); useful only in the immediate acute phase, not for confirming IgE-mediated sensitization. Serum tryptase (not listed) would be a better acute-phase marker. ### Mechanism In Type I hypersensitivity, penicillin acts as a hapten, binding to serum proteins to form immunogenic conjugates. IgE antibodies are produced and bind to mast cell/basophil Fc receptors. Re-exposure cross-links surface IgE, triggering degranulation with release of histamine, tryptase, leukotrienes, and prostaglandins. Intradermal skin testing reproduces this local mast cell response, confirming sensitization. *Reference: Roitt's Immunology, 8th ed.; EAACI Drug Allergy Guidelines; Middleton's Allergy, 9th ed.*
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.